Dr Reddy’s
- COVID-19
Dr Reddy’s Received First Consignment of Sputnik V
Subsequently, the supply of the Sputnik V vaccine will start from Indian manufacturing partners. The imported doses of the vaccine…
Read More » - Digital Security
Cyber Attack on Dr Reddy’s Labs Is a Strong Wake Up Alarm: Cybersecurity Experts
According to a report by HSBC, damage control and restoration of operations are crucial. It said Dr Reddy's is a…
Read More » - Healthcare
Dr Reddy’s Launched Remdesivir as Redyx for Indian Market
The launch is part of a licensing agreement with Gilead Sciences Inc that grants Dr Reddy's the right to register,…
Read More » - COVID-19
After Zydus Cadila and Jubilant Life, Dr. Reddy’s Signs Licensing Agreement with Gilead Sciences for Remdesivir
This deal will be valid in 127 countries including India. Gilead Sciences has signed a non-exclusive licensing agreement with Zydus…
Read More » - Global
Dr Reddy’s Launches Heartburn Drug in US Market
Dr Reddy’s Laboratories launched Omeprazole delayed-release tablets, used to treat frequent heartburn, in the US market. “Dr Reddy’s Laboratories has…
Read More » - News
Brainstorming for Making India’s Growth Story at India-US Technology Summit
The biggest priority for every single bureaucrat, minister, politicians and even individual citizen of India is to contribute in the…
Read More » - Analysis
‘Russia is always an Opportunity for Indian Businesses’
Specially with the advent global business opportunity that are expected to come through FDI in Defence and FDI in general,…
Read More »